Compare POET & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POET | AVNS |
|---|---|---|
| Founded | 1972 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.2M | 521.7M |
| IPO Year | N/A | N/A |
| Metric | POET | AVNS |
|---|---|---|
| Price | $6.11 | $11.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 8.0M | 514.6K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $762,695.00 | ★ $699,900,000.00 |
| Revenue This Year | $2,939.08 | $3.07 |
| Revenue Next Year | $710.17 | $2.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 535.87 | 2.70 |
| 52 Week Low | $3.09 | $9.30 |
| 52 Week High | $9.41 | $17.75 |
| Indicator | POET | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 52.69 | 58.76 |
| Support Level | $5.81 | $11.59 |
| Resistance Level | $6.59 | $12.02 |
| Average True Range (ATR) | 0.56 | 0.36 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 52.46 | 93.81 |
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.